{"entity":{"id":"d4836c84-ec5d-524e-afca-00a4842bf331","name":"Lettmann Jason","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001688269","risk":"MED","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"as_observed":"Edges carry the date we OBSERVED them in a source registry, not a validity period. We do not currently hold ownership end dates, so a link shown here may have ended. Check the source record before relying on currency.","direct_owners":[],"holdings":[{"role":"officer","share":null,"source":"SEC EDGAR (Form 3/4/5)","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"officer","share":null,"source":"SEC EDGAR (Form 3/4/5)","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"officer","share":null,"source":"SEC EDGAR (Form 3/4/5)","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"officer","share":null,"source":"SEC EDGAR","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"tenpercentowner","share":null,"source":"SEC EDGAR","subsidiary":{"id":"214eea60-ceaf-51c7-93bc-e0673112a143","name":"ALX ONCOLOGY HOLDINGS INC","type":"Company","kind":"company","identifier":"sec:0001810182"}},{"role":"tenpercentowner","share":null,"source":"SEC EDGAR","subsidiary":{"id":"085b3b15-4911-5fa9-89d8-fdfaa952e167","name":"RA PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001481512"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"085b3b15-4911-5fa9-89d8-fdfaa952e167","name":"RA PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001481512"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (aircraft/sanctioned vessels/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing.","mcp":{"install":"npx -y @whiteintel/mcp-server","tools":["get_dossier","trace_ownership_path","check_offshore_exposure"],"note":"Call this dossier as a tool from your agent; buy in-flow with get_pricing/buy_dossier/get_payment_link."}},"source":"corpus"}